544 related articles for article (PubMed ID: 22476347)
1. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
[TBL] [Abstract][Full Text] [Related]
2. EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway.
Li H; Zhang B; Liu Y; Yin C
Med Oncol; 2014 Sep; 31(9):162. PubMed ID: 25119502
[TBL] [Abstract][Full Text] [Related]
3. Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN.
Zheng J; Dai Y; Yang Z; Yang L; Peng Z; Meng R; Xiong Y; He J
Oncol Rep; 2016 Jan; 35(1):530-7. PubMed ID: 26531778
[TBL] [Abstract][Full Text] [Related]
4. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
Zhang X; Diaz MR; Yee D
Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
[TBL] [Abstract][Full Text] [Related]
5. EBP50 suppresses the proliferation of MCF-7 human breast cancer cells via promoting Beclin-1/p62-mediated lysosomal degradation of c-Myc.
Liu H; Zhao WL; Wang JP; Xin BM; Shao RG
Acta Pharmacol Sin; 2018 Aug; 39(8):1347-1358. PubMed ID: 29283175
[TBL] [Abstract][Full Text] [Related]
6. Function of RasGRP3 in the formation and progression of human breast cancer.
Nagy Z; Kovács I; Török M; Tóth D; Vereb G; Buzás K; Juhász I; Blumberg PM; Bíró T; Czifra G
Mol Cancer; 2014 Apr; 13():96. PubMed ID: 24779681
[TBL] [Abstract][Full Text] [Related]
7. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
[TBL] [Abstract][Full Text] [Related]
8. Ezrin-Radixin-Moesin Binding Phosphoprotein 50 (EBP50) Suppresses the Metastasis of Breast Cancer and HeLa Cells by Inhibiting Matrix Metalloproteinase-2 Activity.
Wang L; Qi Y; Xiong Y; Peng Z; Ma Q; Zhang Y; Song J; Zheng J
Anticancer Res; 2017 Aug; 37(8):4353-4360. PubMed ID: 28739728
[TBL] [Abstract][Full Text] [Related]
9. EBP50 promotes focal adhesion turnover and vascular smooth muscle cells migration.
Song GJ; Leslie KL; Barrick S; Bougoin S; Taboas JM; Bisello A
J Mol Cell Cardiol; 2012 Dec; 53(6):809-19. PubMed ID: 22974528
[TBL] [Abstract][Full Text] [Related]
10. Periodic Mechanical Stress Activates PKCδ-Dependent EGFR Mitogenic Signals in Rat Chondrocytes via PI3K-Akt and ERK1/2.
He P; Shen N; Gao G; Jiang X; Sun H; Zhou D; Xu N; Nong L; Ren K
Cell Physiol Biochem; 2016; 39(4):1281-94. PubMed ID: 27606614
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes.
Nunes M; Shi C; Greenberger LM
Mol Cancer Ther; 2004 Jan; 3(1):21-7. PubMed ID: 14749472
[TBL] [Abstract][Full Text] [Related]
12. Role of epidermal growth factor receptor (EGFR)-signaling versus cellular acidosis via Na+/H+ exchanger1(NHE1)-inhibition in troglitazone-induced growth arrest of breast cancer-derived cells MCF-7.
Friday E; Oliver R; Welbourne T; Turturro F
Cell Physiol Biochem; 2007; 20(6):751-62. PubMed ID: 17982257
[TBL] [Abstract][Full Text] [Related]
13. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.
Sah JF; Eckert RL; Chandraratna RA; Rorke EA
J Biol Chem; 2002 Mar; 277(12):9728-35. PubMed ID: 11788593
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor (EGFR)-mediated positive feedback of protein-tyrosine phosphatase epsilon (PTPepsilon) on ERK1/2 and AKT protein pathways is required for survival of human breast cancer cells.
Nunes-Xavier CE; Elson A; Pulido R
J Biol Chem; 2012 Jan; 287(5):3433-44. PubMed ID: 22117074
[TBL] [Abstract][Full Text] [Related]
15. PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling.
Liu HJ; Ooms LM; Srijakotre N; Man J; Vieusseux J; Waters JE; Feng Y; Bailey CG; Rasko JE; Price JT; Mitchell CA
J Biol Chem; 2016 Aug; 291(33):17258-70. PubMed ID: 27358402
[TBL] [Abstract][Full Text] [Related]
16. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
17. Cell surface protein C23 affects EGF-EGFR induced activation of ERK and PI3K-AKT pathways.
Lv S; Dai C; Liu Y; Sun B; Shi R; Han M; Bian R; Wang R
J Mol Neurosci; 2015 Feb; 55(2):519-24. PubMed ID: 25015231
[TBL] [Abstract][Full Text] [Related]
18. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
[TBL] [Abstract][Full Text] [Related]
19. Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells.
Kavarthapu R; Dufau ML
Oncotarget; 2016 Oct; 7(40):65602-65613. PubMed ID: 27564112
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of EGF/EGFR activation with naphtho[1,2-b]furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells.
Hsieh CY; Tsai PC; Tseng CH; Chen YL; Chang LS; Lin SR
Toxicol In Vitro; 2013 Feb; 27(1):1-10. PubMed ID: 23064031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
